vs

Side-by-side financial comparison of COMPUGEN LTD (CGEN) and Marwynn Holdings, Inc. (MWYN). Click either name above to swap in a different company.

COMPUGEN LTD is the larger business by last-quarter revenue ($3.5M vs $2.3M, roughly 1.5× Marwynn Holdings, Inc.). Marwynn Holdings, Inc. runs the higher net margin — -116.0% vs -410.1%, a 294.1% gap on every dollar of revenue. On growth, Marwynn Holdings, Inc. posted the faster year-over-year revenue change (-13.3% vs -61.8%).

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

Marwynn Holdings, Inc. is a Canada-based investment holding company focused on acquiring, managing, and scaling middle-market businesses primarily across North America. Its core operating segments cover industrial products, consumer goods, and technology-enabled services, targeting sustainable long-term value creation for its stakeholders.

CGEN vs MWYN — Head-to-Head

Bigger by revenue
CGEN
CGEN
1.5× larger
CGEN
$3.5M
$2.3M
MWYN
Growing faster (revenue YoY)
MWYN
MWYN
+48.4% gap
MWYN
-13.3%
-61.8%
CGEN
Higher net margin
MWYN
MWYN
294.1% more per $
MWYN
-116.0%
-410.1%
CGEN

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
CGEN
CGEN
MWYN
MWYN
Revenue
$3.5M
$2.3M
Net Profit
$-14.5M
$-2.7M
Gross Margin
42.4%
Operating Margin
-475.1%
-115.8%
Net Margin
-410.1%
-116.0%
Revenue YoY
-61.8%
-13.3%
Net Profit YoY
-54.7%
-11713.9%
EPS (diluted)
$-0.16
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGEN
CGEN
MWYN
MWYN
Q3 25
$2.3M
Q2 25
$3.5M
Q1 25
$623.7K
Q2 24
$9.3M
Q1 24
$2.6M
Q2 23
$0
Net Profit
CGEN
CGEN
MWYN
MWYN
Q3 25
$-2.7M
Q2 25
$-14.5M
Q1 25
$23.4K
Q2 24
$-9.4M
Q1 24
$7.3M
Q2 23
$-18.6M
Gross Margin
CGEN
CGEN
MWYN
MWYN
Q3 25
42.4%
Q2 25
Q1 25
39.2%
Q2 24
60.5%
Q1 24
17.9%
Q2 23
Operating Margin
CGEN
CGEN
MWYN
MWYN
Q3 25
-115.8%
Q2 25
-475.1%
Q1 25
13.5%
Q2 24
-128.5%
Q1 24
Q2 23
Net Margin
CGEN
CGEN
MWYN
MWYN
Q3 25
-116.0%
Q2 25
-410.1%
Q1 25
3.8%
Q2 24
-101.4%
Q1 24
284.0%
Q2 23
EPS (diluted)
CGEN
CGEN
MWYN
MWYN
Q3 25
$-0.16
Q2 25
$-0.16
Q1 25
$0.00
Q2 24
$-0.10
Q1 24
$89505618.00
Q2 23
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGEN
CGEN
MWYN
MWYN
Cash + ST InvestmentsLiquidity on hand
$35.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$50.3M
$2.3M
Total Assets
$106.5M
$11.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGEN
CGEN
MWYN
MWYN
Q3 25
Q2 25
$35.3M
Q1 25
$480
Q2 24
$44.6M
Q1 24
$39.3M
Q2 23
$21.6M
Stockholders' Equity
CGEN
CGEN
MWYN
MWYN
Q3 25
$2.3M
Q2 25
$50.3M
Q1 25
$2.4M
Q2 24
$58.3M
Q1 24
$65.6M
Q2 23
$62.0M
Total Assets
CGEN
CGEN
MWYN
MWYN
Q3 25
$11.6M
Q2 25
$106.5M
Q1 25
$12.6M
Q2 24
$110.2M
Q1 24
$121.3M
Q2 23
$77.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGEN
CGEN
MWYN
MWYN
Operating Cash FlowLast quarter
$-18.6M
$-95.1K
Free Cash FlowOCF − Capex
$-18.8M
FCF MarginFCF / Revenue
-530.8%
Capex IntensityCapex / Revenue
6.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGEN
CGEN
MWYN
MWYN
Q3 25
$-95.1K
Q2 25
$-18.6M
Q1 25
Q2 24
$39.7M
Q1 24
Q2 23
$-18.6M
Free Cash Flow
CGEN
CGEN
MWYN
MWYN
Q3 25
Q2 25
$-18.8M
Q1 25
Q2 24
$39.7M
Q1 24
Q2 23
$-18.6M
FCF Margin
CGEN
CGEN
MWYN
MWYN
Q3 25
Q2 25
-530.8%
Q1 25
Q2 24
428.3%
Q1 24
Q2 23
Capex Intensity
CGEN
CGEN
MWYN
MWYN
Q3 25
Q2 25
6.5%
Q1 25
Q2 24
0.4%
Q1 24
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CGEN
CGEN

Segment breakdown not available.

MWYN
MWYN

Other$1.3M57%
Revenue From Recyclable Ewaste Materials Sales$1.0M43%

Related Comparisons